Therefore, the present narrative review aims to provide an updated coverage of the following two topics: 1) pathobiologic roles of IL-4 and IL-13 in type-2 asthma; 2) therapeutic effects of dupilumab in severe asthma. This evidence concerns the gene IL4 and asthma.